Effects of clinical decision support on initial dosing and monitoring of tobramycin and amikacin

scientific article

Effects of clinical decision support on initial dosing and monitoring of tobramycin and amikacin is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2146/AJHP100155
P932PMC publication ID3060379
P698PubMed publication ID21411805
P5875ResearchGate publication ID50409373

P2093author name stringLemuel R Waitman
Cori L Nelsen
Jacob A McCoy
Josh F Peterson
Zachary L Cox
P2860cites workKinetic model for gentamicin dosing with the use of individual patient parametersQ52859214
The effective use of gentamicin in life-threatening sepsisQ54744317
Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: gentamicin in burn patientsQ67779622
Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumoniaQ70386358
Tobramycin penetration into epithelial lining fluid of patients with pneumoniaQ74649799
Incorporation of a gentamicin dosage calculator into a computerized prescriber-order-entry systemQ79816391
The epidemiology of prescribing errors: the potential impact of computerized prescriber order entryQ79913879
Errors associated with applying decision support by suggesting default doses for aminoglycosidesQ80196346
Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated PneumoniaQ22241905
Role of computerized physician order entry systems in facilitating medication errorsQ28238872
Prediction of creatinine clearance from serum creatinineQ29615603
Effects of computerized physician order entry and clinical decision support systems on medication safety: a systematic reviewQ31147557
Computer support for determining drug dose: systematic review and meta-analysisQ33589737
Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicityQ33977062
Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study GroupQ34313874
Individualised aminoglycoside dosage based on pharmacokinetic analysis is superior to dosage based on physician intuition at achieving target plasma drug concentrationsQ34397569
Impact of computerized physician order entry on clinical practice in a newborn intensive care unitQ35661416
Effectiveness of combination antimicrobial therapy for Pseudomonas aeruginosa bacteremiaQ35685688
Medication-related clinical decision support in computerized provider order entry systems: a reviewQ36407786
Back to the future: using aminoglycosides again and how to dose them optimallyQ36916092
Effects of a pharmacist-to-dose computerized request on promptness of antimicrobial therapyQ37020609
Experience with a once-daily aminoglycoside program administered to 2,184 adult patientsQ39779327
Practical computer-assisted dosing for aminoglycoside antibioticsQ39874941
Implementation and evaluation of vancomycin nomogram guidelines in a computerized prescriber-order-entry systemQ43203817
A prospective randomised trial comparing individualised pharmacokinetic dosage prediction for aminoglycosides with prediction based on estimated creatinine clearance in critically ill patientsQ43446209
Effect of once-daily dosing vs. multiple daily dosing of tobramycin on enzyme markers of nephrotoxicityQ44245415
Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentrationQ44483617
Effect on amphotericin B lipid complex use of a clinical decision support system for computerized prescriber order entry.Q45002162
2006 national clinical pharmacy services survey: clinical pharmacy services, collaborative drug management, medication errors, and pharmacy technologyQ46836754
Developing and implementing clinical decision support for use in a computerized prescriber-order-entry systemQ48663802
A controlled trial of the cost benefit of computerized bayesian aminoglycoside administration.Q52447951
P433issue7
P407language of work or nameEnglishQ1860
P921main subjectdecision support systemQ330268
amikacinQ408529
P304page(s)624-632
P577publication date2011-04-01
P1433published inAmerican Journal of Health-System PharmacyQ15754037
P1476titleEffects of clinical decision support on initial dosing and monitoring of tobramycin and amikacin
P478volume68

Reverse relations

cites work (P2860)
Q54324308Acute kidney injury: Global health alert.
Q33871939Acute kidney injury: global health alert
Q58358374Acute kidney injury: global health alert
Q58358387Acute kidney injury: global health alert
Q37912135Adopting real-time surveillance dashboards as a component of an enterprisewide medication safety strategy
Q37406323Computerized physician order entry: promise, perils, and experience
Q50048343Improving medication-related clinical decision support.
Q38160639Neutrophil gelatinase associated lipocalin in acute kidney injury
Q36039089Real-time pharmacy surveillance and clinical decision support to reduce adverse drug events in acute kidney injury: a randomized, controlled trial
Q35986250Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious Diseases
Q37426469Systematic review of clinical decision support interventions with potential for inpatient cost reduction

Search more.